Company: IXHL
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043682
Chunk: 1

Company: Incannex Healthcare Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
30, 2024 respectively 
     2  
     2 
  
     Preferred stock, $0.0001 par value per share, 10,000,000 shares authorized; no shares issued or outstanding at March 31, 2025 and June 30, 2024, respectively 
     -  
     - 
  
    Additional paid-in capital 
     136,849  
     125,218 
  
    Accumulated deficit 
     (125,953) 
     (110,671)
  
    Foreign currency translation reserve 
     (3,495) 
     (3,332)
  
    Total stockholders’ equity 
     7,403  
     11,217 
  
    Total liabilities and stockholders’ equity 
    $16,197  
    $17,047 

The accompanying notes are an integral part of
these condensed consolidated financial statements.

1

INCANNEX HEALTHCARE INC.

Condensed Consolidated Statements of Operations
and Comprehensive Loss

(unaudited)

(in thousands, except share and per share amounts)

(expressed
in U.S. Dollars, unless otherwise stated)

    For the three months ended
 March 31,  
    For the 9 months ended
 March 31, 

    2025  
    2024  
    2025  
    2024 
  
    Revenue from customers 
     -  
     -  
     86  
     - 
  
    Operating expenses: 

    Research and development 
     (2,735) 
     (3,277) 
     (7,045) 
     (8,520)
  
    General and administrative 
     (2,268) 
     (4,138) 
     (9,302) 
     (11,777)
  
    Total operating expenses 
     (5,003) 
     (7,415) 
     (16,347) 
     (20,297)
  
    Loss from operations 
     (5,003) 
     (7,415) 
     (16,261) 
     (20,297)
  
    Other income, net: 
     -  
     -  
     -  
     - 
  
    R&D tax incentive 
     421